Search Site
  • 0
    Mon panier

    Click Here to Find How Many Items You Have Added:)

    image loader

    Adding item(s) to cart......

Accueil >> Lipids

Lipids

Products for  Lipids

  1. Cat.No. Nom du produit Informations
  2. GC40816 α-Linolenoyl Ethanolamide

    N-Linolenoyl Ethanolamine

     α-Linolenoyl ethanolamide is an endocannabinoid containing α-linolenic acid in place of the arachidonate moiety of AEA. α-Linolenoyl Ethanolamide Chemical Structure
  3. GC41262 (±)-α-CMBHC Vitamin E is a well known antioxidant that exists in eight natural forms: four tocopherols (α, β, δ, and γ) and four tocotrienols (α, β, δ, and γ). (±)-α-CMBHC Chemical Structure
  4. GC14406 (±)-Acetylcarnitine chloride

    Acetyl dl-carnitine chloride

     weak cholinergic agonist; intermediates in lipid metabolism (±)-Acetylcarnitine chloride Chemical Structure
  5. GC15834 (±)-Decanoylcarnitine chloride intermediate in lipid metabolism (±)-Decanoylcarnitine chloride Chemical Structure
  6. GC17351 (±)-Hexanoylcarnitine chloride

    intermédiaires importants dans le métabolisme des lipides

     (±)-Hexanoylcarnitine chloride Chemical Structure
  7. GC45882 (±)-Jasmonic Acid-d5 A neuropeptide with diverse biological activities (±)-Jasmonic Acid-d5 Chemical Structure
  8. GC16427 (±)-Lauroylcarnitine chloride important intermediates in lipid metabolism (±)-Lauroylcarnitine chloride Chemical Structure
  9. GC10056 (±)-Myristoylcarnitine chloride

    cholinergic agonist; important intermediates in lipid metabolism

     (±)-Myristoylcarnitine chloride Chemical Structure
  10. GC13909 (±)-Octanoylcarnitine chloride homolog of acetylcarnitine chloride (±)-Octanoylcarnitine chloride Chemical Structure
  11. GC49510 (±)-Tuberonic Acid

    12-hydroxy Jasmonic Acid, 12-hydroxy epi-Jasmonic Acid

     A derivative of jasmonic acid (±)-Tuberonic Acid Chemical Structure
  12. GC45269 (±)10(11)-DiHDPA

    (±)10,11-DiHDPE

     (±)10(11)-DiHDPA is produced from cytochrome P450 epoxygenase action on docosahexaenoic acid. (±)10(11)-DiHDPA Chemical Structure
  13. GC45270 (±)10(11)-EDP Ethanolamide

    10,11-EDP-EA, 10,11-EDP epoxide, 10,11-epoxy Docosapentaenoic Ethanolamide

     (±)10(11)-EDP ethanolamide is an ω-3 endocannabinoid epoxide and cannabinoid (CB) receptor agonist (EC50s = 0.43 and 22.5 nM for CB1 and CB2 receptors, respectively). (±)10(11)-EDP Ethanolamide Chemical Structure
  14. GC41212 (±)10(11)-EpDPA

    (±)10,11-EDP, (±)10,11-EpDPE, (±)10,11-epoxy DPA, (±)10,11-epoxy Docosapentaenoic Acid

     Cytochrome P450 metabolism of polyunsaturated fatty acids produces numerous bioactive epoxide regioisomers. (±)10(11)-EpDPA Chemical Structure
  15. GC91064 (±)10,11-EDT

    Un métabolite de l'acide adrénique.

     (±)10,11-EDT Chemical Structure
  16. GC41213 (±)10-HDHA

    10hydroxy Docosahexaenoic Acid, (±)10HDoHE

    (±)10-HDHA is an autoxidation product of docosahexaenoic acid (DHA) in vitro.

     (±)10-HDHA Chemical Structure
  17. GC46252 (±)11(12)-DiHET-d11

    (±)11(12)-DHET-d11, (±)11,12-DiHETrE-d11

     A neuropeptide with diverse biological activities (±)11(12)-DiHET-d11 Chemical Structure
  18. GC41214 (±)11-HDHA

    11hydroxy Docosahexaenoic Acid, (±)11-HDoHE

     (±)11-HDHA is an autoxidation product of docosahexaenoic acid (DHA) in vitro. (±)11-HDHA Chemical Structure
  19. GC41648 (±)13(14)-DiHDPA

    13(14)-DiHDPA, 13(14)-DiHDoPE, 13,14-DiHDPE

     (±)13(14)-DiHDPA is a metabolite of docosahexaenoic acid that is produced via oxidation by cytochrome P450 epoxygenases. (±)13(14)-DiHDPA Chemical Structure
  20. GC41191 (±)13(14)-EpDPA

    (±)13,14-EDP, (±)13,14-EpDPE, (±)13,14-epoxy DPA, (±)13,14-epoxy Docosapentaenoic Acid

     (M)13(14)-EpDPA (13,14-EpDPE) est le produit de la réaction de la cytochrome P-450 époxygénase avec l'acide docosahexaénoïque (DHA). (±)13(14)-EpDPA Chemical Structure
  21. GC91066 (±)13,14-DiHDoTrE

    Un oxylipine

     (±)13,14-DiHDoTrE Chemical Structure
  22. GC91065 (±)13,14-EDT

    Un métabolite de l'acide adrénique.

     (±)13,14-EDT Chemical Structure
  23. GC41192 (±)13-HDHA

    13hydroxy Docosahexaenoic Acid, (±)13-HDoHE

     (±)13-HDHA is an autoxidation product of docosahexaenoic acid (DHA) in vitro. (±)13-HDHA Chemical Structure
  24. GC46258 (±)14(15)-DiHET-d11

    (±)14,15-DiHETrE-d11

     A neuropeptide with diverse biological activities (±)14(15)-DiHET-d11 Chemical Structure
  25. GC41193 (±)14-HDHA

    14hydroxy Docosahexaenoic Acid, (±)14-HDoHE

     (±)14-HDHA is an autoxidation product of docosahexaenoic acid (DHA) in vitro. (±)14-HDHA Chemical Structure
  26. GC91722 (±)15,16-DiHODE

    FA 18:2;O2,(±)15,16-Dihydroxyoctadecadienoic Acid,(±)15,16-dihydroxy-cis-9,12-Octadecadienoic Acid,(±)15,16-dihydroxy-9(Z),12(Z)-ODE

     (±)15,16-DiHODE is an α-linolenic acid-derived oxylipin. (±)15,16-DiHODE Chemical Structure
  27. GC41653 (±)16(17)-DiHDPA (±)16(17)-DiHDPA is produced from cytochrome P450 epoxygenase action on docosahexaenoic acid. (±)16(17)-DiHDPA Chemical Structure
  28. GC41194 (±)16(17)-EpDPA

    (±)16,17 EDP, (±)16,17-epoxy Docosapentaenoic Acid, (±)16,17-epoxy DPA, (±)16,17-EpDPE

    EDHF (endothelium-derived hyperpolarizing factor) is an unidentified mediator released from vascular endothelial cells in response to acetylcholine and bradykinin which is distinct from the NOS- (nitric oxide) and COX-derived (prostacyclin) vasodilators.

     (±)16(17)-EpDPA Chemical Structure
  29. GC41195 (±)16(17)-EpDPA MaxSpec® Standard EDHF (endothelium-derived hyperpolarizing factor) is an unidentified mediator released from vascular endothelial cells in response to acetylcholine and bradykinin which is distinct from the NOS- (nitric oxide) and COX-derived (prostacyclin) vasodilators. (±)16(17)-EpDPA MaxSpec® Standard Chemical Structure
  30. GC91067 (±)16,17-EDT

    Un métabolite de l'acide adrénique.

     (±)16,17-EDT Chemical Structure
  31. GC41196 (±)16-HDHA

    16hydroxy Docosahexaenoic Acid, (±)16-HDoHE

     (±)16-HDHA is an autoxidation product of docosahexaenoic acid (DHA) in vitro. (±)16-HDHA Chemical Structure
  32. GC41197 (±)17-HDHA

    17-hydroxy Docosahexaenoic Acid, 17-hydroxy DHA, (±)17-HDoHE

     (±)17-HDHA is an autoxidation product of docosahexaenoic acid in vitro. (±)17-HDHA Chemical Structure
  33. GC41198 (±)17-HDHA MaxSpec® Standard

    17-hydroxy Docosahexaenoic Acid, 17-hydroxy DHA, (±)17-HDoHE

     (±)17-HDHA is an autoxidation product of docosahexaenoic acid in vitro. (±)17-HDHA MaxSpec® Standard Chemical Structure
  34. GC41654 (±)19(20)-DiHDPA

    (±)19,20DiHDoPE

     Docosahexaenoic acid is an essential fatty acid and the most abundant ω-3 fatty acid in neural tissues, especially in the retina and brain. (±)19(20)-DiHDPA Chemical Structure
  35. GC40388 (±)19(20)-DiHDTE

    (±)19(20)-DiHDoTE

     (±)19(20)-DiHDTE is an oxylipin and an oxidative metabolite of docosapentaenoic acid. (±)19(20)-DiHDTE Chemical Structure
  36. GC41655 (±)19(20)-EDP Ethanolamide

    19,20-DHEA epoxide, 19,20-epoxy Docosapentaenoic Acid Ethanolamide, 19,20-EDP-EA, 19,20-EDP epoxide

     (±)19(20)-EDP ethanolamide is an ω-3 endocannabinoid epoxide and cannabinoid (CB) receptor agonist (EC50s = 108 and 280 nM for CB1 and CB2, respectively). (±)19(20)-EDP Ethanolamide Chemical Structure
  37. GC41199 (±)19(20)-EpDPA

    (±)19,20 EDP, (±)19,20-epoxy Docosapentaenoic Acid, (±)19,20-epoxy DPA, (±)19,20-EpDPE

     EDHF (endothelium-derived hyperpolarizing factor) is an unidentified mediator released from vascular endothelial cells in response to acetylcholine and bradykinin which is distinct from the NOS- (nitric oxide) and COX-derived (prostacyclin) vasodilators. (±)19(20)-EpDPA Chemical Structure
  38. GC40905 (±)19(20)-EpDTE

    (±)19(20)-EpDoTE

     (±)19(20)-EpDTE is an oxylipin and an oxidative metabolite of docosapentaenoic acid. (±)19(20)-EpDTE Chemical Structure
  39. GC91574 (±)2-HOTrE

    FA 18:3;O,(±)2-9(Z),12(Z),15(Z)-HOTrE,α-Hydroxylinolenic Acid,2-Hydroxylinolenic Acid,(±)-2-hydroxy-9(Z),12(Z),15(Z)-OTrE

     (±)2-HOTrE is an oxylipin. (±)2-HOTrE Chemical Structure
  40. GC41201 (±)4(5)-DiHDPA lactone (±)5(6)-DiHET lactone is a 1,5 cyclic ester derived from (±)5(6)-DiHET, which, in turn, is a potential derivative of epoxidation of arachidonic acid at the α-5 double bond. (±)4(5)-DiHDPA lactone Chemical Structure
  41. GC41660 (±)4(5)-EpDPA methyl ester

    (±)4,5EDP methyl ester, (±)4,5epoxy Docosapentaenoic Acid methyl ester, (±)4,5epoxy DPA methyl ester, (±)4(5)-EpDPE methyl ester

     (±)4(5)-EpDPA methyl ester is a derivative of (±)4(5)-EpDPA which is stable enough to ship and handle routinely. (±)4(5)-EpDPA methyl ester Chemical Structure
  42. GC41202 (±)4-HDHA

    4hydroxy Docosahexaenoic Acid, (±)4HDoHE

     (±)4-HDHA is an autoxidation product of docosahexaenoic acid (DHA) in vitro. (±)4-HDHA Chemical Structure
  43. GC46263 (±)5-iPF2α-VI-d11 An internal standard for the quantification of (±)5iPF2αVI (±)5-iPF2α-VI-d11 Chemical Structure
  44. GC91713 (±)6(7)-EpODE(γ)

    FA 18:3;O,(±)6(7)-epoxy-γ-Octadecadienoic Acid,(±)6(7)-epoxy-9(Z),12(Z)-ODE(γ)

     (±)6(7)-EpODE(γ) is an oxylipin. (±)6(7)-EpODE(γ) Chemical Structure
  45. GC91725 (±)6,7-DiHODE(γ)

    (±)6,7-dihydroxy-cis-9,12-γ-Octadecadienoic Acid,(±)6,7-dihydroxy-γ-Octadecadienoic Acid,(±)6,7-dihydroxy-9(Z),12(Z)-ODE(γ),FA 18:2;O2

     (±)6,7-DiHODE(γ) is an oxylipin. (±)6,7-DiHODE(γ) Chemical Structure
  46. GC41663 (±)7(8)-DiHDPA (±)7(8)-DiHDPA is a major metabolite of docosahexaenoic acid that is produced via oxidation by cytochrome P450 epoxygenases. (±)7(8)-DiHDPA Chemical Structure
  47. GC40389 (±)7(8)-DiHDTE

    (±)7(8)-DiHDoTE

     (±)7(8)-DiHDTE is an oxylipin and an oxidative metabolite of docosapentaenoic acid. (±)7(8)-DiHDTE Chemical Structure
  48. GC41203 (±)7(8)-EpDPA

    (±)7,8-EDP, (±)7,8-EpDPE, (±)7,8-epoxy DPA, (±)7,8-epoxy Docosapentaenoic Acid

     Docosahexaenoic acid is the most abundant ω-3 fatty acid in neural tissues, especially in the brain and retina. (±)7(8)-EpDPA Chemical Structure
  49. GC40906 (±)7(8)-EpDTE

    (±)7(8)-EpDoTE

     (±)7(8)-EpDTE is an oxylipin and an oxidative metabolite of docosapentaenoic acid. (±)7(8)-EpDTE Chemical Structure
  50. GC91062 (±)7(S),8(R)-EDT

    Un oxylipine

     (±)7(S),8(R)-EDT Chemical Structure
  51. GC91753 (±)7,8-DiHDoTrE

    (±)7,8-DHDT

     (±)7,8-DiHDoTrE is an oxylipin. (±)7,8-DiHDoTrE Chemical Structure
  52. GC41664 (±)7-epi Jasmonic Acid

    2iso Jasmonic Acid, 7iso Jasmonic Acid

    (±)-7-epi Jasmonic acid is the major metabolite of the 12-oxo phytodienoic acid pathway of the metabolism of 13(S)-hydroperoxy linolenic acid in plants.

     (±)7-epi Jasmonic Acid Chemical Structure
  53. GC41204 (±)7-HDHA

    7hydroxy Docosahexaenoic Acid, (±)7HDoHE

    (±)7-HDHA is an autoxidation product of docosahexaenoic acid (DHA) in vitro.

     (±)7-HDHA Chemical Structure
  54. GC40421 (±)8(9)-EE-14(Z)-E

    (±)8,9-Epoxyeicosa-14(Z)-enoic Acid

     (±)14(15)-EE-8(Z)-E is a potent vasodilator in bovine coronary arteries. (±)8(9)-EE-14(Z)-E Chemical Structure
  55. GC46265 (±)8,9-DiHET-d11

    (±)8,9DiHETrEd11

     A neuropeptide with diverse biological activities (±)8,9-DiHET-d11 Chemical Structure
  56. GC41205 (±)8-HDHA

    8hydroxy Docosahexaenoic Acid, (±)8HDoHE

     (±)8-HDHA is an autoxidation product of docosahexaenoic acid (DHA) in vitro. (±)8-HDHA Chemical Structure
  57. GC91645 (±)9(10)-EpODE

    FA 18:3;O,(±)9(10)-epoxy-12(Z),15(Z)-ODE,(±)9(10)-epoxyoctadecadienoic Acid

     (±)9(10)-EpODE is an oxylipin. (±)9(10)-EpODE Chemical Structure
  58. GC91714 (±)9(10)-EpODE(γ)

    (±)9(10)-epoxy-6(Z),12(Z)-ODE(γ),(±)9(10)-epoxy-cis-6,12-γ-Octadecadienoic Acid,(±)9(10)-epoxy-γ-Octadecadienoic Acid,FA 18:3;O

     (±)9(10)-EpODE(γ) is an oxylipin. (±)9(10)-EpODE(γ) Chemical Structure
  59. GC91519 (±)9,10-DiHODE

    (±)9,10-dihydroxy-12(Z),15(Z)-ODE,(±)9,10-dihydroxy-cis-12,15-Octadecadienoic Acid,(±)9,10-Dihydroxyoctadecadienoic Acid,FA 18:2;O2

     (±)9,10-DiHODE is an α-linolenic acid-derived oxylipin. (±)9,10-DiHODE Chemical Structure
  60. GC91724 (±)9,10-DiHODE(γ)

    FA 18:2;O2,(±)9,10-dihydroxy-cis-6,12-γ-Octadecadienoic Acid,(±)9,10-dihydroxy-γ-Octadecadienoic Acid,(±)9,10-hydroxy-6(Z),12(Z)-ODE(γ)

     (±)9,10-DiHODE(γ) is an oxylipin. (±)9,10-DiHODE(γ) Chemical Structure
  61. GC40541 (±)9-HODE

    (±)9-HODE is one of the two racemic monohydroxy fatty acids resulting from the non-enzymatic oxidation of linoleic acid.

     (±)9-HODE Chemical Structure
  62. GC50004 (+/-)-Decanoylcarnitine chloride Intermediate in lipid metabolism (+/-)-Decanoylcarnitine chloride Chemical Structure
  63. GC91736 (-)-11-hydroxy-δ8-THC-d3 (exempt preparation)

    (-)-11-hydroxy-δ8-Tetrahydrocannabinol-d3,(-)-trans-δ8-THC-d3,7-hydroxy-δ6-THC-d3

     (−)-11-hydroxy-Δ8-THC-d3 (exempt preparation) is intended for use as an internal standard for the quantification of (−)-11-hydroxy-Δ8-THC by GC- or LC-MS. (-)-11-hydroxy-δ8-THC-d3 (exempt preparation) Chemical Structure
  64. GC91644 (-)-11-hydroxy-δ9-THC

    (-)-7-hydroxy-δ1-Tetrahydrocannabinol,(-)-11-hydroxy-δ9-Tetrahydrocannabinol,(-)-7-hydroxy-δ1-THC

     (–)-11-hydroxy-Δ9-THC is an analytical reference standard categorized as a phytocannabinoid metabolite. (-)-11-hydroxy-δ9-THC Chemical Structure
  65. GC91517 (3β,4β,17β)-17-(2-Pyridinylmethyl)androst-5-ene-3,4,17-triol (3β,4β,17β)-17-(2-Pyridinylmethyl)androst-5-ene-3,4,17-triol is a sterol lipid and derivative of 5-androstenetriol . (3β,4β,17β)-17-(2-Pyridinylmethyl)androst-5-ene-3,4,17-triol Chemical Structure
  66. GC40444 (5Z,11Z,15R)-15-Hydroxyeicosa-5,11-dien-13-ynoic Acid

    HETE Analog 1, Hydroxyeicosatetraenoic Acid Analog 1

     (5Z,11Z,15R)-15-Hydroxyeicosa-5,11-dien-13-ynoic acid is a stable isomer of 15(S)-HETE, a major arachidonic acid metabolite from the 15-lipoxygenase pathway. (5Z,11Z,15R)-15-Hydroxyeicosa-5,11-dien-13-ynoic Acid Chemical Structure
  67. GC41709 (R)-(+)-Docosahexaenyl-1'-Hydroxy-2'-Propylamide N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group. (R)-(+)-Docosahexaenyl-1'-Hydroxy-2'-Propylamide Chemical Structure
  68. GC41705 (R)-(-)-Docosahexaenyl-2'-Hydroxy-1'-Propylamide N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group. (R)-(-)-Docosahexaenyl-2'-Hydroxy-1'-Propylamide Chemical Structure
  69. GC41712 (R)-3-hydroxy Myristic Acid

    (R)-3-hydroxy Tetradecanoic Acid

     Lipopolysaccharides (LPS) are components of the cell walls of Gram-negative bacteria. (R)-3-hydroxy Myristic Acid Chemical Structure
  70. GC41728 (S)-(+)-Docosahexaenyl-2'-Hydroxy-1'-Propylamide N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group. (S)-(+)-Docosahexaenyl-2'-Hydroxy-1'-Propylamide Chemical Structure
  71. GC41724 (S)-(-)-Docosahexaenyl-1'-Hydroxy-2'-Propylamide N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group. (S)-(-)-Docosahexaenyl-1'-Hydroxy-2'-Propylamide Chemical Structure
  72. GC91502 (S)-C12-200

    C12-200-S

     (S)-C12-200 is an ionizable cationic lipid (pKa = 7.12) and an isomer of C12-200 . (S)-C12-200 Chemical Structure
  73. GC46356 (Z)-9-Hexadecenol

    (9Z)-Hexadecen-1-ol, cis-9-Hexadecenol, Palmitoleyl Alcohol, (Z)-9-Hexadecen-1-ol, Z9-16:OH

     An unsaturated long-chain fatty alcohol with diverse biological activities (Z)-9-Hexadecenol Chemical Structure
  74. GC19461 (±)13-HODE

    (±)13-HODE is one of the two racemic monohydroxy fatty acids resulting from the non-enzymatic oxidation of linoleic acid.

     (±)13-HODE Chemical Structure
  75. GC41857 1',4"-Sophorolactone 6',6"-diacetate 1',4"-Sophorolactone 6',6"-diacetate is a major glycolipid produced from fermentation of sugar by yeasts including C. 1',4
  76. GC91299 1,2(R)-Dioleyloxy-3-dimethylamino-propane

    Un lipide cationique ionisable

     1,2(R)-Dioleyloxy-3-dimethylamino-propane Chemical Structure
  77. GC90744 1,2-Dioleoyl-3(R)-trimethylammoniumpropane (chloride)

    Un lipide cationique

     1,2-Dioleoyl-3(R)-trimethylammoniumpropane (chloride) Chemical Structure
  78. GC90745 1,2-Dioleoyl-3(S)-trimethylammoniumpropane (chloride)

    Un lipide cationique

     1,2-Dioleoyl-3(S)-trimethylammoniumpropane (chloride) Chemical Structure
  79. GC18352 1,2-Dioleoyl-3-dimethylammonium-propane

    18:1 DAP

     Le 1,2-dioléoyl-3-diméthylammonium-propane est un lipide cationique. 1,2-Dioleoyl-3-dimethylammonium-propane Chemical Structure
  80. GC45783 1,2-Dioleoyl-rac-glycerol-13C3 An internal standard for the quantification of 1,2-dioleoyl-rac-glycerol 1,2-Dioleoyl-rac-glycerol-13C3 Chemical Structure
  81. GC41817 1,2-Dioleyloxy-3-dimethylamino-propane

    DODMA; MBN 305A

     Le 1,2-dioleyloxy-3-diméthylamino-propane, un lipide cationique, est utilisé pour la préparation de liposomes. 1,2-Dioleyloxy-3-dimethylamino-propane Chemical Structure
  82. GC45306 1,6-Diphenyl-1,3,5-hexatriene

    Diphenylhexatriene, DPH, NSC 90479

     Le 1,6-diphényl-1,3,5-hexatriène est une sonde fluorescente. 1,6-Diphenyl-1,3,5-hexatriene Chemical Structure
  83. GC91804 1-A-N 1-A-N is an ionizable cationic lipid (pKa = 6.8) that has been used in the generation of lipid nanoparticles (LNPs) for siRNA delivery in vivo. 1-A-N Chemical Structure
  84. GC91429 1-Arachidoyl Lysophosphatidic Acid (sodium salt)

    1-Arachidoyl LPA; 1-Eicosanoyl-Lysophosphatidic Acid; LPA(20:0)

    1-L'acide arachidoyl lysophosphatidique (1-arachidoyl LPA) est un agoniste du récepteur de l'acide lysophosphatidique 1 (LPA1) et un glycérophospholipide contenant de l'acide arachidique à la position sn-1.

     1-Arachidoyl Lysophosphatidic Acid (sodium salt) Chemical Structure
  85. GC91785 1-Arachidoyl-2-hydroxy-sn-glycero-3-PA (sodium salt)

    LPA 20:0,PA(20:0/0:0),1-Arachidoyl LPA,1-Arachidoyl Lysophosphatidic Acid,1-Eicosanoyl-2-hydroxy-sn-glycero-3-phosphate,20:0 LPA

     1-Arachidoyl-2-hydroxy-sn-glycero-3-PA (1-arachidoyl LPA) is an agonist of lysophosphatidic acid receptor 1 (LPA1) and a glycerophospholipid containing arachidic acid at the sn-1 position. 1-Arachidoyl-2-hydroxy-sn-glycero-3-PA (sodium salt) Chemical Structure
  86. GC91522 1-Docosahexaenoyl-rac-glycerol

    1-Docosahexaenoin,MAG-DHA,MG(22:6/0:0/0:0)

     1-Docosahexaenoyl-rac-glycerol is a monoacylglycerol that contains docosahexaenoic acid (DHA;) at the sn-1 position. 1-Docosahexaenoyl-rac-glycerol Chemical Structure
  87. GC91811 1-Linoleoyl-d11-2-Linoleoyl-sn-glycero-3-PC

    1,2-Dilinoleoyl-sn-glycero-3-Phosphocholine-d11,DLPC-d11,18:2 (cis) PC-d11

     1-Linoleoyl-d11-2-linoleoyl-sn-glycero-3-PC is intended for use as an internal standard for the quantification of 1,2-dilinoleoyl-sn-glycero-3-PC by GC- or LC-MS. 1-Linoleoyl-d11-2-Linoleoyl-sn-glycero-3-PC Chemical Structure
  88. GC91687 1-Myristoyl-2-Linoleoyl-sn-glycero-3-PC

    1-Myristoyl-2-Linoleoyl-sn-glycero-3-Phosphatidylcholine,1-Myristoyl-2-Linoleoyl-sn-glycero-3-Phosphocholine,PC(14:0/18:2),14:0/18:2-PC

     1-Myristoyl-2-linoleoyl-sn-glycero-3-PC is a phospholipid that contains myristic acid and linoleic acid at the sn-1 and sn-2 positions, respectively. 1-Myristoyl-2-Linoleoyl-sn-glycero-3-PC Chemical Structure
  89. GC91784 1-Myristoyl-d7-2-hydroxy-sn-glycero-3-PC

    14:0-d7 Lyso-PC,1-Myristoyl-d7-sn-glycero-3-Phosphatidylcholine

     1-Myristoyl-d7-2-hydroxy-sn-glycero-3-PC is intended for use as an internal standard for the quantification of 1-myristoyl-2-hydroxy-sn-glycero-3-PC by GC- or LC-MS. 1-Myristoyl-d7-2-hydroxy-sn-glycero-3-PC Chemical Structure
  90. GC91808 1-Myristoyl-d7-2-Linoleoyl-sn-glycero-3-PC

    1-Myristoyl-d7-2-Linoleoyl-sn-glycero-3-Phosphatidylcholine,1-Myristoyl-d7-2-Linoleoyl-sn-glycero-3-Phosphocholine,PC(14:0-d7/18:2),14:0-d7/18:2-PC

     1-Myristoyl-d7-2-linoleoyl-sn-glycero-3-PC is intended for use as an internal standard for the quantification of 1-myristoyl-2-linoleoyl-sn-glycero-3-PC by GC- or LC-MS. 1-Myristoyl-d7-2-Linoleoyl-sn-glycero-3-PC Chemical Structure
  91. GC91394 1-Myristyl-2-hydroxy-sn-glycero-3-PA

    PA(O-14:0/0:0); PA(14:0/0:0); LPA O-14:0; O-14:0 LPA; 1-Myristyl LPA; 1-Myristyl Lysophosphatidic Acid; 1-Tetradecyl-2-hydroxy-sn-glycero-3-phosphate

    1- Le 1-myristyl-2-hydroxy-sn-glycéro-3-PA (LPA de myristyle) est un dérivé de LPA contenant de l'acide myristique à la position sn-1 et un agoniste des récepteurs d'acide lysophosphatidique 1 (LPA1) et LPA2.

     1-Myristyl-2-hydroxy-sn-glycero-3-PA Chemical Structure
  92. GC91421 1-Oleyl-2-hydroxy-sn-glycero-3-PA (sodium salt)

    LPA O-18:0; O-18:0 LPA; 1-Octadecyl-2-hydroxy-sn-glycero-3-phosphate; 1-Octadecyl LPA; 1-Octadecyl Lysophosphatidic Acid; 1-Oleyl LPA; 1-Oleyl Lysophosphatidic Acid; PA(O-18:0/0:0)

    1-Oleyl-2-hydroxy-sn-glycéro-3-PA (1-Octadécyl LPA) est un analogue de LPA contenant de l'alcool stéarylique à la position sn-1.

     1-Oleyl-2-hydroxy-sn-glycero-3-PA (sodium salt) Chemical Structure
  93. GC91676 1-Palmitoleoyl-2-hydroxy-sn-glycero-3-PC

    1-Hexadecenoyl-2-hydroxy-sn-glycero-3-PC,LPC(16:1),16:1 Lyso PC,PC(16:1/0:0)

     1-Palmitoleoyl-2-hydroxy-sn-glycero-3-PC is a lysophospholipid. 1-Palmitoleoyl-2-hydroxy-sn-glycero-3-PC Chemical Structure
  94. GC91620 1-Palmitoyl-d9-2-hydroxy-sn-glycero-3-PA

    1-Hexadecanoyl-d9-2-hydroxy-sn-glycero-3-phosphate,16:0-d9 LPA,LPA 16:0-d9,PA(16:0-d9/0:0),1-Palmitoyl-d9 LPA,1-Palmitoyl-d9 Lysophosphatidic Acid

     1-Palmitoyl-d9-2-hydroxy-sn-glycero-3-PA (1-palmitoyl-d9 LPA) is intended for use as an internal standard for the quantification of 1-palmitoyl LPA by GC- or LC-MS. 1-Palmitoyl-d9-2-hydroxy-sn-glycero-3-PA Chemical Structure
  95. GC91413 1-Palmityl-2-hydroxy-sn-glycero-3-PA (sodium salt)

    1-Hexadecyl-2-hydroxy-sn-glycero-3-phosphate; 1-Hexadecyl LPA; 1-Hexadecyl Lysophosphatidic Acid; LPA O-16:0; O-16:0 LPA; PA(O-16:0/0:0); 1-Palmityl LPA; 1-Palmityl Lysophosphatidic Acid

    1-Palmityl-2-hydroxy-sn-glycéro-3-PA (sel de sodium) est un analogue éther de l'acide lysophosphatidique (LPA) contenant un groupe hexadécyle à la position sn-1.

     1-Palmityl-2-hydroxy-sn-glycero-3-PA (sodium salt) Chemical Structure
  96. GC45317 1-Pyrenesulfonic Acid (sodium salt)   1-Pyrenesulfonic Acid (sodium salt) Chemical Structure
  97. GC40971 10(S),17(S)-DiHDHA

    10(S),17(S)-DiHDoHE, PDX, Protectin DX

     La 10(S),17(S)-DiHDHA (également connue sous le nom de neuroprotectine D1 lorsqu'elle est produite dans les tissus neuronaux) est un acide gras dihydroxy dérivé du DHA qui présente de puissantes activités protectrices et anti-inflammatoires. 10(S),17(S)-DiHDHA Chemical Structure
  98. GC48802 10(S)-HOME

    HOD

     An oxylipin 10(S)-HOME Chemical Structure
  99. GC40423 11(S)-HEDE 11(S)-HEDE is isolated by the chromatographic resolution of (±)11-HEDE. 11(S)-HEDE Chemical Structure
  100. GC40369 11(S)-HEPE 11(S)-HEPE is a monohydroxy fatty acid derived from EPA, theoretically by the action of COX. 11(S)-HEPE Chemical Structure
  101. GC40446 11(S)-HETE

    11(S)-Hydroxyeicosatetraenoic Acid

     11(S)-HETE is an oxylipin and the (S) enantiomer of 11(R)-HETE. It is formed non-enzymatically from arachidonic acid. 11(S)-HETE Chemical Structure

Articles 1 à 100 sur un total de 473

par page
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Par ordre décroissant